Guizhou Plans to Add 114 Oral Healthcare Service Price Items; Straumann China Industry-Academia-Research Center Launches in Shanghai; Dentium Q3 China Revenue Falls 42%; Dental Staffing Platform Raises USD 45 Million…

Guizhou Plans to Standardize and Integrate Oral Healthcare Service Pricing: 114 New Items Added, 448 Discontinued

The Guizhou Provincial Medical Security Bureau recently issued a public notice soliciting feedback on the Notice on Adding Oral Healthcare Service Price Items (Draft for Comment), with a comment deadline of December 2, 2025.

The draft proposes adding 114 new oral healthcare service price items while discontinuing 448 existing items. The new items refine malocclusion correction services for different developmental stages, including standard and complex classifications for "primary dentition malocclusion correction fees."

The draft requires municipal medical security bureaus to account for differences in service output and cost composition when implementing new prices, ensuring that charges for the same service type remain broadly consistent.

The draft also requires all prefecture-level cities and autonomous prefectures to expedite the rollout of new oral healthcare service pricing, with full implementation no later than March 1, 2026.

On November 13, 2025, Swiss Straumann Group officially launched its first implant manufactured in Shanghai, China, for the global market.

The Shanghai facility is Straumann's third-largest implant production base worldwide, adhering strictly to global unified quality standards. It integrates more advanced smart manufacturing equipment and information systems than the Swiss facility, fully replicating Swiss end-to-end quality standards. Each implant undergoes more than 30 manufacturing steps, with monitored characteristic values exceeding regulatory requirements by tenfold.

The center aims to build an integrated development ecosystem. In terms of education and training, a dental clinic on the ground floor will host live surgical demonstrations, symposia, and professional training events. In terms of innovation and R&D, the center will partner with China's leading universities and hospitals to identify and incubate early-stage domestic technology projects, accelerating the clinical translation of cutting-edge research.

Dentium recently released its Q3 2025 financial results. Third-quarter revenue was KRW 78.2 billion (approximately RMB 423 million), down 17% year-over-year; operating profit was KRW 12.5 billion (approximately RMB 68 million), down 49% year-over-year.

China market revenue was KRW 28.5 billion (approximately RMB 154 million), down 42% year-over-year, primarily due to sustained economic pressure and weakening demand. The company plans to strengthen its localization strategy in China in 2026 to improve performance.

Implant and equipment business revenue was KRW 70.0 billion (approximately RMB 378 million), down 20% year-over-year; consumables and merchandise revenue was KRW 8.221 billion (approximately RMB 44 million), up 7% year-over-year.

As of the end of Q3, total assets were KRW 907.0 billion (approximately RMB 4.898 billion), and total liabilities were KRW 348.1 billion (approximately RMB 1.88 billion).

Regal Medical Group recently issued a positive profit alert, projecting pre-tax profit of no less than RMB 20 million for the first half of fiscal year 2026 (six months ended September 30, 2025), representing a year-over-year increase of more than 170%.

The company attributed the profit growth to AI-enabled clinical management, recovering patient demand, and strict cost-reduction and efficiency-improvement initiatives.

According to prior reporting, Regal Medical Group's mid-year revenue for fiscal year 2025 was RMB 887 million, up 0.1% year-over-year. The company expected to release its interim results on November 28, 2025, with detailed financial information to be disclosed at that time.

Data from the National Enterprise Credit Information Publicity System shows that between November 10–17, 2025, Saide Sunshine Dental founder Zhou Yanheng was densely appointed as legal representative for 13 dental clinics and related companies across Beijing, Shenzhen, Guangzhou, Changsha, Liuzhou, Xiamen, and Cangzhou.

As of the time of publication, Saide Sunshine Medical Group operates 30 dental healthcare institutions.

U.S. dental talent marketplace GoTu Technology recently announced a USD 45 million (approximately RMB 324 million) growth investment round led by Long Ridge Equity Partners, with participation from institutional investors under J.P. Morgan Asset Management.

The funding will support GoTu's nationwide U.S. expansion, accelerate marketplace development, and launch new services.

Founded in 2019 and headquartered in Miami, GoTu has a team of more than 120 employees and has filled over 500,000 dental positions across 44 states and Washington, D.C.

According to the American Dental Association's (ADA) Q4 2024 survey, more than 90% of respondents described hiring dental hygienists as "extremely difficult" or "very difficult."

The Guangxi Zhuang Autonomous Region Drug Regulatory Authority recently released the Guangxi Medical Device Business Enterprise Quality Safety Principal Responsibility List and the Guangxi Medical Device Business Enterprise Quality Safety Negative List, aimed at urging medical device distributors to fulfill their quality safety responsibilities and standardize business conduct.

The principal responsibility list includes 46 items covering full-process management requirements such as business licensing, quality management, and sales records. The negative list specifies 28 prohibited acts—including distributing products without a medical device registration certificate—along with corresponding legal liabilities.

The "dual list" was developed in accordance with relevant regulations and will be dynamically updated as laws and policies evolve.

The Inner Mongolia Autonomous Region Medical Security Bureau recently issued a notice soliciting public comments on the Inner Mongolia Autonomous Region Medical Security Designated Medical Institution Credit Evaluation Implementation Rules (Draft for Comment), with feedback due by November 28, 2025.

The rules specify that credit evaluation cycles for designated medical institutions are one year, with scoring conducted via a deduction-based method and credit ratings divided into four tiers. Under the rules, institutions with higher credit ratings may enjoy incentives such as exemptions from inspections, while those with lower ratings will face double-frequency inspections and may be listed as dishonest entities.

Dishonest institutions may apply for credit restoration within the validity period and must provide supporting documentation.

U.S. additive manufacturing company Carbon recently announced the completion of a USD 60 million (approximately RMB 426 million) funding round, with participation from Sequoia Capital, Silver Lake, Adidas, and other investors. The funding will be used to expand production capacity and consolidate its sustainable business model in additive manufacturing.

Founded in 2013, Carbon focuses on large-scale production of high-performance polymer components and has launched multiple products in the medical, industrial, and consumer goods markets.

The company disclosed that its dental customers produce millions of customized 3D-printed components per week, and it has partnered with Keystone Industries to launch flexible partial denture products.

U.S. digital dentistry company Dandy recently launched AI Scan Review, a chairside AI assistant that detects crown preparation defects in real time.

The system is embedded within Dandy's chairside scanning software and can identify undercuts, marginal obstructions, and insufficient occlusal clearance, alerting dentists promptly and providing step-by-step guidance.

Unlike other scanning software, AI Scan Review analyzes defects on each tooth surface in depth, processing millions of data points to help reduce the likelihood of remakes.

Dandy's co-founder stated that this launch marks a significant milestone in the company's effort to eliminate remakes and reflects its full-workflow optimization strategy.

Global dental technology provider Henry Schein One recently announced a partnership with Amazon Web Services (AWS) to integrate generative AI into its dental management platforms—Dentrix, Dentrix Ascend, and Dentally.

The platform will offer real-time documentation assistants, voice-activated periodontal charting, predictive business intelligence, automated claims verification, and AI-driven scheduling tools to personalize patient experiences.

Leveraging AWS infrastructure, the intelligent platform will expand to the U.S., U.K., and EU markets to ensure global interoperability and consistent care standards.

Henry Schein One plans to create the industry's first AI-centric ecosystem to support all types of dental care workflows.

The American Dental Association (ADA) recently submitted a letter to the Senate Finance Committee calling for oral health to be incorporated into the national healthcare cost reform strategy.

The ADA put forward five policy recommendations, emphasizing the close relationship between oral health and overall health, and advocating for a focus on prevention and early intervention to eliminate financial barriers to diagnostic and preventive dental services.

The ADA also opposed the use of annual and lifetime maximum benefit caps in dental benefits, called for increased transparency through the establishment of a "dental medical loss ratio" standard.

Additionally, the ADA advocated for comprehensive adult dental benefits and supports tax incentives such as Health Savings Accounts. The ADA expressed its hope that the Senate Finance Committee will adopt its recommendations and pledged to continue serving as a resource for analyzing healthcare cost drivers.

The British Dental Association (BDA) has criticized the "Find a Dentist" feature on the NHS England website for providing false information, saying it masks the true severity of the dental services crisis.

A BBC investigation found that of 34 practices in northeast England listed as accepting new patients, only three actually had available appointments—all located in Newcastle. All 24 practices in areas such as Northumberland were not accepting new patients. One practice reported a waiting list of four years.

NHS England did not offer an explanation, stating it had provided clinics with updated tools and expressed determination to improve dental service accessibility. Patients expressed frustration, highlighting that demand for NHS services far exceeds supply.

A double-blind, placebo-controlled randomized clinical trial completed at the Faculty of Dentistry, Chulalongkorn University, found that curcumin mouthwash did not significantly reduce the incidence or healing time of traumatic ulcers in patients with fixed orthodontic appliances. However, it provided better pain relief during the first two weeks of wearing orthodontic appliances, with the curcumin group recording lower pain scores than the placebo group (p > 0.05).

The study noted that traumatic ulcers are a common complication of orthodontic treatment, and the early analgesic effect of curcumin may have clinical value in helping patients adapt to orthodontic appliances. The researchers recommended that larger-scale clinical trials be conducted to further clarify the adjunctive therapeutic role of curcumin.

A joint study by Complutense University of Madrid and University College London found that antidepressant users had a 59% lower risk of developing severe periodontitis.

The study was based on data from the U.S. National Health and Nutrition Examination Survey and analyzed 9,839 adults aged 30 and over. Results showed that the prevalence of periodontitis was significantly lower among antidepressant users compared to non-users.

Data showed that antidepressant users had reduced prevalence in both Stage II–IV and Stage III–IV periodontitis, with systemic inflammatory markers playing a partial mediating role in this association.

The research team suggested that antidepressants may influence periodontal health through multiple pathways, including anti-inflammatory properties, inhibition of osteoclasts, and reduced risks of diabetes and hypertension. The study emphasized the need for further longitudinal research to verify the mechanisms by which antidepressants affect periodontal health.

The Tianjin Municipal Drug Administration recently issued an administrative penalty against a medical device company for manufacturing substandard disposable oral instrument sets, with fines and confiscations totaling RMB 39,500.

The batch of products failed a 2025 Xinjiang medical device supervisory sampling inspection, with forceps measuring 141–142 mm in total length—falling short of the required 155 mm ± 5 mm technical specification. The company did not request a re-inspection after receiving the inspection report.

The products were manufactured on January 8, 2025, in Wuqing District, totaling 10,000 sets, with illegal gains of RMB 9,500. The Tianjin Municipal Drug Administration determined that the conduct violated the Regulations on the Supervision and Administration of Medical Devices and imposed penalties in accordance with the law.

Scan the QR code to read more oral industry news.